Engineering Synthetic Gene Circuits in Living Cells with CRISPR Technology

Trends in Biotechnology

Volumn 34, Issue 7, 2016, Pages 535-547

  Jusiak, Barbara ^a   Cleto, Sara ^a   Perez Piñera, Pablo ^b   Lu, Timothy K ^a  

^a USA   (United States)

^b University of Illinois at Urbana Champaign   (United States)

Author keywords

CRISPR Cas9; Gene circuits; Synthetic biology; Synthetic transcription factors

Indexed keywords

CELL ENGINEERING; CELLS; CHEMICAL ACTIVATION; CYTOLOGY; GENE EXPRESSION; GENES; MAMMALS; MEDICAL APPLICATIONS; RECONFIGURABLE HARDWARE; TRANSCRIPTION; TRANSCRIPTION FACTORS;

BIOMEDICAL APPLICATIONS; CRISPR-CAS9; GENE CIRCUITS; REGULATORY CIRCUITS; SYNTHETIC BIOLOGY; SYNTHETIC GENE CIRCUITS; SYNTHETIC TRANSCRIPTION; TRANSCRIPTIONAL REGULATION;

GENE EXPRESSION REGULATION;

SYNTHETIC DNA;

CELL SPECIFICITY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE CONTROL; GENE FUNCTION; GENE INDUCTION; GENE REGULATORY NETWORK; GENE REPRESSION; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNTHETIC BIOLOGY; TRANSCRIPTION INITIATION; GENE EDITING; GENE TARGETING; GENETIC RECOMBINATION; PROCEDURES;

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; GENE EDITING; GENE REGULATORY NETWORKS; GENE TARGETING; GENETIC ENGINEERING; RECOMBINATION, GENETIC; SYNTHETIC BIOLOGY;

EID: 84956857435     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2015.12.014     Document Type: Review

References (87)

1. Brophy J.A., Voigt C.A. Principles of genetic circuit design. Nat. Methods 2014, 11:508-520.
2. Lienert F., et al. Synthetic biology in mammalian cells: next generation research tools and therapeutics. Nat. Rev. Mol. Cell Biol. 2014, 15:95-107.
3. Liu C.C., et al. An adaptor from translational to transcriptional control enables predictable assembly of complex regulation. Nat. Methods 2012, 9:1088-1094.
4. Lohmueller J.J., et al. A tunable zinc finger-based framework for Boolean logic computation in mammalian cells. Nucleic Acids Res. 2012, 40:5180-5187.
5. Moon T.S., et al. Genetic programs constructed from layered logic gates in single cells. Nature 2012, 491:249-253.
6. Siuti P., et al. Synthetic circuits integrating logic and memory in living cells. Nat. Biotechnol. 2013, 31:448-452.
7. Auslander S., et al. Programmable single-cell mammalian biocomputers. Nature 2012, 487:123-127.
8. Daniel R., et al. Synthetic analog computation in living cells. Nature 2013, 497:619-623.
9. Gardner T.S., et al. Construction of a genetic toggle switch in Escherichia coli. Nature 2000, 403:339-342.
10. Deans T.L., et al. A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells. Cell 2007, 130:363-372.
11. Stricker J., et al. A fast, robust and tunable synthetic gene oscillator. Nature 2008, 456:516-519.
12. Ellis T., et al. Diversity-based, model-guided construction of synthetic gene networks with predicted functions. Nat. Biotechnol. 2009, 27:465-471.
13. Friedland A.E., et al. Synthetic gene networks that count. Science 2009, 324:1199-1202.
14. Danino T., et al. A synchronized quorum of genetic clocks. Nature 2010, 463:326-330.
15. Tabor J.J., et al. A synthetic genetic edge detection program. Cell 2009, 137:1272-1281.
16. Basu S., et al. A synthetic multicellular system for programmed pattern formation. Nature 2005, 434:1130-1134.
17. Farzadfard F., Lu T.K. Synthetic biology Genomically encoded analog memory with precise in vivo DNA writing in living cell populations. Science 2014, 346:1256272.
18. Auslander D., et al. A designer cell-based histamine-specific human allergy profiler. Nat. Commun. 2014, 5:4408.
19. You L., et al. Programmed population control by cell-cell communication and regulated killing. Nature 2004, 428:868-871.
20. Bacchus W., et al. Synthetic two-way communication between mammalian cells. Nat. Biotechnol. 2012, 30:991-996.
21. Barrangou R., et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007, 315:1709-1712.
22. Marraffini L.A., Sontheimer E.J. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 2008, 322:1843-1845.
23. Deltcheva E., et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 2011, 471:602-607.
24. Jinek M., et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337:816-821.
25. Mali P., et al. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
26. Jiang W., et al. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 2013, 31:233-239.
27. DiCarlo J.E., et al. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res. 2013, 41:4336-4343.
28. Mojica F.J., et al. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 2009, 155:733-740.
29. Shah S.A., et al. Protospacer recognition motifs: mixed identities and functional diversity. RNA Biol. 2013, 10:891-899.
30. Qi L.S., et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013, 152:1173-1183.
31. Bikard D., et al. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 2013, 41:7429-7437.
32. Gilbert L.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-451.
33. Perez-Pinera P., et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat. Methods 2013, 10:973-976.
34. Maeder M.L., et al. CRISPR RNA-guided activation of endogenous human genes. Nat. Methods 2013, 10:977-979.
35. Mali P., et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 2013, 31:833-838.
36. Farzadfard F., et al. Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas. ACS Synth. Biol. 2013, 2:604-613.
37. Cheng A.W., et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res. 2013, 23:1163-1171.
38. Gilbert L.A., et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 2014, 159:647-661.
39. Tanenbaum M.E., et al. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 2014, 159:635-646.
40. Chavez A., et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 2015, 12:326-328.
41. Zalatan J.G., et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 2015, 160:339-350.
42. Konermann S., et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 2015, 517:583-588.
43. Hilton I.B., et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 2015, 33:510-517.
44. Sander J.D., Joung J.K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 2014, 32:347-355.
45. Hsu P.D., et al. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014, 157:1262-1278.
46. Margolin J.F., et al. Krüppel-associated boxes are potent transcriptional repression domains. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:4509-4513.
47. Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol. 2003, 4:231.
48. Mittler G., et al. A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. EMBO J. 2003, 22:6494-6504.
49. Nissim L., et al. Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol. Cell 2014, 54:698-710.
50. Kabadi A.M., et al. Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Res. 2014, 42:e147.
51. Kiani S., et al. CRISPR transcriptional repression devices and layered circuits in mammalian cells. Nat. Methods 2014, 11:723-726.
52. Liu Y., et al. Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells. Nat. Commun. 2014, 5:5393.
53. Nielsen A.A., Voigt C.A. Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks. Mol. Syst. Biol. 2014, 10:763.
54. Mimee M., et al. Programming a human commensal bacterium Bacteroides thetaiotaomicron, to sense and respond to stimuli in the murine gut microbiota. Cell Syst. 2015, 1:62-71.
55. Wang B., et al. Engineering modular and orthogonal genetic logic gates for robust digital-like synthetic biology. Nat. Commun. 2011, 2:508.
56. Blount B.A. Rational diversification of a promoter providing fine-tuned expression and orthogonal regulation for synthetic biology. PLoS ONE 2012, 7:e33279.
57. Khalil A.S., et al. A synthetic biology framework for programming eukaryotic transcription functions. Cell 2012, 150:647-658.
58. Esvelt K.M., et al. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 2013, 10:1116-1121.
59. Orioli A., et al. RNA polymerase III transcription control elements: themes and variations. Gene 2012, 493:185-194.
60. Gao Y., Zhao Y. Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing. J. Integr. Plant Biol. 2014, 56:343-349.
61. Shechner D.M., et al. Multiplexable, locus-specific targeting of long RNAs with CRISPR-Display. Nat. Methods 2015, 12:664-670.
62. Nihongaki Y., et al. CRISPR-Cas9-based photoactivatable transcription system. Chem. Biol. 2015, 22:169-174.
63. Polstein L.R., Gersbach C.A. A light-inducible CRISPR-Cas9 system for control of endogenous gene activation. Nat. Chem. Biol. 2015, 11:198-200.
64. Fu Y., et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 2013, 31:822-826.
65. Pattanayak V., et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 2013, 31:839-843.
66. Khalil A.S., Collins J.J. Synthetic biology: applications come of age. Nat. Rev. Genet. 2010, 11:367-379.
67. Cheng A.A., Lu T.K. Synthetic biology: an emerging engineering discipline. Annu. Rev. Biomed. Eng. 2012, 14:155-178.
68. Boyle P.M., Silver P.A. Parts plus pipes: synthetic biology approaches to metabolic engineering. Metab. Eng. 2012, 14:223-232.
69. Ye H., et al. Synthetic mammalian gene circuits for biomedical applications. Curr. Opin. Chem. Biol. 2013, 17:910-917.
70. O'Connell M.R., et al. Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature 2014, 516:263-266.
71. Citorik R.J., et al. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 2014, 32:1141-1145.
72. Cheng A.A., et al. Enhanced killing of antibiotic-resistant bacteria enabled by massively parallel combinatorial genetics. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:12462-12467.
73. Wong A.S., et al. Massively parallel high-order combinatorial genetics in human cells. Nat. Biotechnol. 2015, 33:952-961.
74. Beerli R.R., Barbas C.F. Engineering polydactyl zinc-finger transcription factors. Nat. Biotechnol. 2002, 20:135-141.
75. Liu Q., et al. Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:5525-5530.
76. Bogdanove A.J., et al. TAL effectors: finding plant genes for disease and defense. Curr. Opin. Plant Biol. 2010, 13:394-401.
77. Beerli R.R., et al. Positive and negative regulation of endogenous genes by designed transcription factors. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1495-1500.
78. Zhang F., et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat. Biotechnol. 2011, 29:149-153.
79. Zhang Z., et al. Dissecting the roles of miR-302/367 cluster in cellular reprogramming using TALE-based repressor and TALEN. Stem Cell Rep. 2013, 1:218-225.
80. Urnov F.D., et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005, 435:646-651.
81. Christian M., et al. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 2010, 186:757-761.
82. Miller J.C., et al. A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 2011, 29:143-148.
83. Beerli R.R., et al. Chemically regulated zinc finger transcription factors. J. Biol. Chem. 2000, 275:32617-32627.
84. Magnenat L., et al. Drug-inducible and simultaneous regulation of endogenous genes by single-chain nuclear receptor-based zinc-finger transcription factor gene switches. Gene Ther. 2008, 15:1223-1232.
85. Mercer A.C., et al. Regulation of endogenous human gene expression by ligand-inducible TALE transcription factors. ACS Synth. Biol. 2013, 3:723-730.
86. Polstein L.R., Gersbach C.A. Light-inducible spatiotemporal control of gene activation by customizable zinc finger transcription factors. J. Am. Chem. Soc. 2012, 134:16480-16483.
87. Konermann S., et al. Optical control of mammalian endogenous transcription and epigenetic states. Nature 2013, 500:472-476.